Celecoxib/Famciclovir

塞来昔布/泛昔洛韦

Report date: 2026/04/29 20:02:18

Base Information

Drug NameCelecoxib/Famciclovir
Drug Alias Name塞来昔布+泛昔洛韦Famciclovir/celecoxibCelecoxib+Famciclovir泛昔洛韦/塞来昔布Famciclovir+celecoxib +[7] 
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Nucleoside analogues
Mechanisms of ActionCyclooxygenase-2 inhibitorsHuman herpesvirus 5 DNA polymerase inhibitorsHuman herpesvirus 1 DNA polymerase inhibitors
TargetsCyclooxygenase-2Human herpesvirus 1 DNA polymeraseHuman herpesvirus 5 DNA polymerase
Therapy Area/IndicationsIrritable Bowel SyndromeFibromyalgia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsYes FamciclovirCelecoxib
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesVirios Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesPRIDCor Therapeutics LLCVirios Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsIrritable Bowel SyndromeFibromyalgia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A